• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基化DNA序列作为癌症生物标志物的临床应用:美国国立癌症研究所环境基因组学和风险评估网络(EDRN)与美国国家标准与技术研究院(NIST)关于标准、方法、检测、试剂及工具的联合研讨会

Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.

作者信息

Kagan Jacob, Srivastava Sudhir, Barker Peter E, Belinsky Steven A, Cairns Paul

机构信息

Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland, USA.

出版信息

Cancer Res. 2007 May 15;67(10):4545-9. doi: 10.1158/0008-5472.CAN-06-2888.

DOI:10.1158/0008-5472.CAN-06-2888
PMID:17510378
Abstract

The workshop report, entitled Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint National Cancer Institute's Early Detection Research Network and National Institute of Standards and Technology Workshop, presents a summary of the main issues, current challenges, outcomes, and recommendations toward application of methylated DNA sequences as cancer biomarkers.

摘要

这份研讨会报告题为《迈向甲基化DNA序列作为癌症生物标志物的临床应用:美国国立癌症研究所早期检测研究网络与美国国家标准与技术研究院联合研讨会》,总结了将甲基化DNA序列用作癌症生物标志物的主要问题、当前挑战、成果及建议。

相似文献

1
Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools.甲基化DNA序列作为癌症生物标志物的临床应用:美国国立癌症研究所环境基因组学和风险评估网络(EDRN)与美国国家标准与技术研究院(NIST)关于标准、方法、检测、试剂及工具的联合研讨会
Cancer Res. 2007 May 15;67(10):4545-9. doi: 10.1158/0008-5472.CAN-06-2888.
2
Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005.早期癌症检测中血浆和血清蛋白质组学标准:美国国家标准与技术研究院需求评估报告——美国国立癌症研究所标准、方法、检测、试剂及技术研讨会,2005年8月18 - 19日
Clin Chem. 2006 Sep;52(9):1669-74. doi: 10.1373/clinchem.2006.067249. Epub 2006 Jul 13.
3
Circulating methylated DNA.循环甲基化DNA
Ann N Y Acad Sci. 2004 Jun;1022:33-9. doi: 10.1196/annals.1318.006.
4
Analysis of methylated circulating DNA in cancer patients' blood.癌症患者血液中甲基化循环DNA的分析
Methods Mol Biol. 2009;507:349-56. doi: 10.1007/978-1-59745-522-0_25.
5
Stool DNA methylation assays in colorectal cancer screening.用于结直肠癌筛查的粪便DNA甲基化检测
World J Gastroenterol. 2015 Sep 21;21(35):10057-61. doi: 10.3748/wjg.v21.i35.10057.
6
Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker.值得装入瓶中的血液:循环肿瘤DNA作为一种癌症生物标志物
Cancer Res. 2016 Oct 1;76(19):5590-5591. doi: 10.1158/0008-5472.CAN-16-2281.
7
Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer.检测微卫星不稳定型结肠癌患者血清中异常甲基化的hMLH1启动子DNA。
Cancer Res. 2001 Feb 1;61(3):900-2.
8
The early detection research network: 10-year outlook.早期检测研究网络:10 年展望。
Clin Chem. 2013 Jan;59(1):60-7. doi: 10.1373/clinchem.2012.184697. Epub 2012 Nov 16.
9
Methylated genes as new cancer biomarkers.甲基化基因作为新型癌症生物标志物。
Eur J Cancer. 2009 Feb;45(3):335-46. doi: 10.1016/j.ejca.2008.12.008. Epub 2009 Jan 12.
10
Circulating nucleic acids (CNAs) and cancer--a survey.循环核酸与癌症——一项调查
Biochim Biophys Acta. 2007 Jan;1775(1):181-232. doi: 10.1016/j.bbcan.2006.10.001. Epub 2006 Oct 7.

引用本文的文献

1
Particulate matter air pollution as a cause of lung cancer: epidemiological and experimental evidence.空气污染中的颗粒物作为肺癌病因:流行病学及实验证据
Br J Cancer. 2025 Jun;132(11):986-996. doi: 10.1038/s41416-025-02999-2. Epub 2025 Apr 4.
2
Epigenetic Alterations and Inflammation as Emerging Use for the Advancement of Treatment in Non-Small Cell Lung Cancer.表观遗传学改变与炎症作为非小细胞肺癌治疗进展的新用途。
Front Immunol. 2022 Apr 20;13:878740. doi: 10.3389/fimmu.2022.878740. eCollection 2022.
3
Molecular tools for the pathologic diagnosis of central nervous system tumors.
用于中枢神经系统肿瘤病理诊断的分子工具。
Neurooncol Pract. 2019 Jan;6(1):4-16. doi: 10.1093/nop/npy041. Epub 2018 Nov 5.
4
DNA Methylation Profiles and Their Diagnostic Utility in BC.BC 中的 DNA 甲基化图谱及其诊断效用。
Dis Markers. 2019 May 6;2019:6328503. doi: 10.1155/2019/6328503. eCollection 2019.
5
Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer.PCDH10异常启动子甲基化作为乳腺癌患者潜在的诊断和预后生物标志物。
Oncol Lett. 2018 Oct;16(4):4462-4470. doi: 10.3892/ol.2018.9214. Epub 2018 Jul 25.
6
Association between MGMT Promoter Methylation and Risk of Breast and Gynecologic Cancers: A Systematic Review and Meta-Analysis.MGMT 启动子甲基化与乳腺癌和妇科癌症风险的关联:系统评价和荟萃分析。
Sci Rep. 2017 Oct 6;7(1):12783. doi: 10.1038/s41598-017-13208-3.
7
DNA methylation profiles in cancer diagnosis and therapeutics.癌症诊断和治疗中的 DNA 甲基化谱。
Clin Exp Med. 2018 Feb;18(1):1-14. doi: 10.1007/s10238-017-0467-0. Epub 2017 Jul 27.
8
Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.用于检测宫颈上皮内瘤变和宫颈癌的候选宿主DNA甲基化标志物的发现与验证
Int J Cancer. 2017 Aug 15;141(4):701-710. doi: 10.1002/ijc.30781. Epub 2017 May 26.
9
Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer.检测血清DNA中六基因panel的异常甲基化用于乳腺癌诊断
Oncotarget. 2016 Apr 5;7(14):18485-94. doi: 10.18632/oncotarget.7608.
10
Particulate matter-induced epigenetic changes and lung cancer.颗粒物诱导的表观遗传变化与肺癌
Clin Respir J. 2017 Sep;11(5):539-546. doi: 10.1111/crj.12389. Epub 2015 Oct 20.